SPTXSeaport Therapeutics, Inc.

HealthcareUSD
$27.92

The financials

Seaport Therapeutics, Inc. by the numbers

Seaport Therapeutics, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$66M−$16Mn/a
Net income−$63M−$13Mn/a
Diluted EPS−$1.78−$5.65n/a

Biotechnology

The closest names by size in the same industry

Compare peers
KYMR+17%
Kymera Therapeutics, Inc.
NRIX+16%
Nurix Therapeutics, Inc.
SLS+15%
SELLAS Life Sciences Group, Inc.
ZBIO+13%
Zenas BioPharma, Inc.
SLBT+12%
SL Science Holding Limited
TSHA-11%
Taysha Gene Therapies, Inc.